Meetings & Events

Update on Acromegaly: Treatment Based on the New Guidelines

July 21, 2020

Session Description: This session will discuss the best strategy to treat patients with acromegaly according to new guidelines and in light of the availability (or not) of biomarkers and new drugs.

Faculty: Shlomo Melmed, MB ChB
Cedar Sinai Medical Center

Learning Objectives:

  1. Translate relevant data published from the new guidelines.
  2. Discuss potential benefits and limitations of biomarkers in drug choice.
  3. Describe the new drugs in the horizon (with special emphasis on the recently FDA approved oral octreotide—which patient will benefit from this drug?).

Return to the full CEU program.

Last Updated:
Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!